Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Medline Inc. (NASDAQ: MDLN)
MDLN Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
9.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
49.50%
MDLN Stock Analysis
MDLN
PE Ratio:
30.2
MDLN
PEG Ratio:
2.5
MDLN
Forward EPS Growth (12 month):
12.20%
MDLN
PS Ratio:
1
MDLN
PSG Ratio:
0.1
MDLN
Forward Revenue Growth (12 month):
7.90%
MDLN Articles
No data was found